Apr. 17, 2012, 10:56 AMWest Pharmaceutical (WST +9.8%) shares break out to an eight-month high after the company issues upside guidance for Q1. WST sees EPS of $0.83, excluding non-recurring items, vs. $0.65 consensus, on revenues of $316M vs. $308M consensus. FY 2012 EPS estimate is raised to $2.50-$2.67 vs. $2.47 consensus. | Comment!
WST vs. ETF Alternatives
West Pharmaceutical Services Inc is a manufacturer of components and systems for injectable drug delivery and plastic packaging and delivery system components for the healthcare and consumer products industries.
Other News & PR